Introduction
The murine respiratory system is first recognizable as two primary lung buds emerge from the ventral foregut endoderm on embryonic day (E) 9.5 (reviewed in Cardoso and Lu (2006) ). These buds elongate and branch in an iterative process, known as branching morphogenesis, to generate the distal respiratory tree. The foregut endoderm rostral to the site of the primary lung buds gives rise to two epithelial tubes: the esophagus and trachea. The mechanisms governing the separation of these two tubes are not entirely clear, but errors in this process carry significant clinical implications in the forms of tracheoesophageal fistula and esophageal atresia (Que et al., 2006) . C-shaped rings of hyaline cartilage encircle the ventrolateral surfaces of the mature trachea and prevent its collapse during respiration. In humans, structural weakness of the trachea, known as tracheomalacia, results in collapse of the airway during respiration (for reviews see Carden et al. (2005) , McNamara and Crabbe (2004) ). Depending on the degree of tracheal collapse, symptoms range from respiratory stridor to fatal airway obstruction. The true incidence of tracheomalacia is not known because many of its symptoms overlap with those of other pulmonary disorders and it is often misdiagnosed; however, estimates range from 1 in 2600 to 1 in 1445 births (Boogaard et al., 2005; Carden et al., 2005) . In some instances, tracheomalacia arises through developmental malformation of the trachea itself; this congenital form is known as primary tracheomalacia (reviewed in Carden et al. (2005) ). Examples of primary tracheomalacia include defects in cartilage matrix production or the shortened cartilage elements observed in patients with tracheoesophageal fistula. In other cases, classified as secondary tracheomalacia, the cause of tracheal collapse is extrinsic to the trachea. Examples of secondary tracheomalacia include trauma and external pressure on the trachea from adjacent organs.
In mice, the tracheal cartilage rings develop in the splanchnic mesenchyme surrounding the trachea between embryonic day (E) 13.5 and E15.5 (Miller et al., 2004) . Sox9, a gene necessary for chondrogenesis, is expressed in bilateral longitudinal stripes along the length of the trachea at E9.0 (Elluru and Whitsett, 2004) . The expression of Col2a1, a major component of the extracellular matrix of cartilage, has been reported in similar domains beginning a day later at E10.0 (Elluru and Whitsett, 2004) . The mechanisms directing the development of tracheal cartilage rings in distinct bands along the rostrocaudal axis in the ventrolateral mesenchyme are not currently known; however, reverse genetic experiments in mice have identified several genes that affect their development. These include Shh (Miller et al., 2004) , Hoxa-5 (Aubin et al., 1997) , Traf4 (Regnier et al., 2002) , FoxF1 (Mahlapuu et al., 2001) , Raldh2 (Vermot et al., 2003) , Wnt7b (Rajagopal et al., 2008) , Fgfr2c (Eswarakumar et al., 2004) , and various retinoic acid receptors (Mendelsohn et al., 1994) . Unfortunately, the characterizations of these mutants have focused on other defects and the molecular events underlying their tracheal cartilage malformations have not been investigated.
The dorsal aspect of the trachea is not cartilaginous; instead, the trachealis muscle spans a gap in each cartilage ring. This smooth muscle regulates the lumen size of the trachea and, along with the cartilage rings, keeps the airway open during respiration (Hakansson et al., 1976) . Surprisingly little is known about the embryology of the trachealis muscle and the genes affecting its development.
Tmem16a is a member of the TMEM16 family of proteins with orthologs in organisms ranging from Saccharomyces cerevisiae to humans (Entian et al., 1999; Katoh and Katoh, 2003) . These proteins contain eight predicted transmembrane domains and a C-terminal domain of unknown function (DUF590; Interpro IPR007632). Human TMEM16A (other published names for this protein include DOG1, TAOS2 and FLJ10621) is amplified in a number of cancers including oral squamous cell carcinoma and gastrointestinal stromal tumors (Huang et al., 2006; West et al., 2004) . Despite this evolutionary conservation and potential clinical significance, the functions of the vertebrate TMEM16 proteins are unknown.
We report that murine Tmem16a is expressed in the epithelium of the developing trachea and in the embryonic trachealis muscle. Mice homozygous for a null allele of Tmem16a failed to thrive during postnatal life. These mice developed ventral gaps in the tracheal rings along the entire rostrocaudal axis of the trachea and abnormal trachealis muscles. Since Tmem16a is not expressed at any stage in the chondrogenic ventrolateral mesenchyme, we propose that the cartilage defect is secondary to defects in the epithelium or trachealis where Tmem16a is expressed. We provide evidence that the defective trachealis muscles and abnormally organized tracheal epithelium in Tmem16a mutant embryos resulted in an abnormal expansion of the trachea that displaced the ventral chondrocytes or changed their identity to a non-chondrogenic lineage. This phenotype caused symptoms that mimic those in humans with tracheomalacia.
Materials and methods

Generation of a null allele of Tmem16a
Arms of homology flanking exon 12 of Tmem16a were PCR amplified from CJ.7 ES cell genomic DNA and cloned into an ES cell targeting vector containing a floxed PGK-neo cassette. The linearized targeting construct was electroporated into 129S1/SvImj derived CJ.7 ES cells (Swiatek and Gridley, 1993) and targeted clones were enriched for by selection with Geneticin (Invitrogen, Carlsbad, CA) and FIAU (Moravek Biochemicals, Brea, CA). Southern blotting confirmed the correct targeting of one ES cell line that was used to generate chimeras by blastocyst injections. Germline transmission of the correctly targeted allele was confirmed by PCR. All experiments were approved by and performed according to the regulations of the Institutional Animal Care and Use Committee of the University of Florida. mRNA was isolated from E11.0 mutant embryos using TRIzol (Invitrogen, Carlsbad, CA) according to the manufacturer's manufacturer's protocol and used to generate cDNA using AMV reverse transcriptase and oligo(dT) primers. Primers flanking the deletion were used to amplify the targeted Tmem16a transcript that was cloned and sequenced to confirm deletion of exon 12 and the downstream frameshift mutation.
Dams or pups were sacrificed by cervical location or carbon dioxide asphyxiation and embryos or tracheae were isolated in PBS prior to fixation overnight at 4°C in 4% paraformaldehyde. Samples were dehydrated, infiltrated with HistoWax (Leica Microsystems, Bannockburn, IL), and embedded in paraffin. Seven micrometer sections were cut on a rotary microtome. For BrdU incorporation, dams were injected with 10 μl/g body weight of 3 mg/ml BrdU in PBS 2 h prior to sacrifice.
Alcian blue staining of cartilage
Whole tracheae or dewaxed and rehydrated 7 μm paraffin sections were stained in 0.03% alcian blue (Fisher Scientific, Pittsburgh, PA) in 25% glacial acetic acid in ethanol. Whole mount samples were cleared by immersion in KOH and glycerol. Sections were counterstained in eosin, dehydrated, and mounted.
RNA in situ hybridization
RNA in situ hybridizations were performed on whole lungs or 14 μm cryosections according to a standard protocol (Nieto et al., 1996) . The plasmid used to generate antisense probe for Tmem16a has been described previously (Rock et al., 2007) .
Immunohistochemistry and immunofluorescence
Sections were dewaxed and rehydrated. Antigen retrieval was performed by microwaving slides for 20 min in 10 mM citric acid (pH6.0) with 0.05% Tween-20 (Fisher Scientific, Pittsburgh, PA). Primary antibodies were used at the following concentrations: rabbit anti-Sox9 at 1:200 (sc-20095, Santa Cruz Biotechnologies, Santa Cruz, CA), goat anti-CC10 at 1:100 (sc-9772, Santa Cruz Biotechnologies) (CC10 is also known as Scgb1a1), mouse anti-p63 at 1:200 (sc-8431, Santa Cruz Biotechnologies), rat anti-Cdh1 at 1:200 (U3254, Sigma, St. Louis, MO), mouse anti-acetylated α-tubulin at 1:100 (Ab24610, Abcam, Cambridge, MA), mouse anti-α smooth muscle actin at 1:100 (clone 1A4, DAKO, Carpinteria, CA), and rat anti-BrdU at 1:50 (OBT0030G, Accurate Chemical, Westbury, NY). p63 was visualized using the MOM kit and Sox9, α-smooth muscle actin, and BrdU were visualized using VectaStain ABC kits (Vector Laboratories, Burlingame, CA) and metal-enhanced DAB (Pierce Biotechnology, Rockford, IL). Sections were counterstained with Richardson's Azure II. Secondary antibodies for immunofluorescence were: Cy2-conjugated donkey anti-goat, Cy3-conjugated donkey anti-rat, and Cy3-conjugated donkey anti-mouse (Jackson ImmunoResearch, West Grove, PA). 4′,6-Diamidino-2′-phenylindole (DAPI, Pierce Biotechnology, Rockford, IL) was used as counterstain.
Immunocytochemistry
The 3.3 kb RsrII-NdeI fragment of EST AK052589 encoding Tmem16a was blunted and ligated into XhoI digested and blunted pAcGFP1-C1 (Clontech, Mountain View, CA). Sequencing the resulting plasmid (pGFP-Tmem16a) confirmed that Tmem16a was in frame 3′ of the GFP coding sequence. KLN 205 cells (American Type Culture Collection, Manassas, VA) were seeded at 10 5 cells per well 24 h prior to transfection with 2 μg of pAcGFP1-C1 or pGFP-Tmem16a using FuGENE 6 (Roche, Basel, Switzerland) according to the manufacturer's protocol. Twenty-four hours after transfection GFP was immunolocalized using polyclonal goat anti-GFP (ab5450, Abcam, Cambridge, MA) and Cy-2 conjugated donkey anti-goat (Jackson ImmunoResearch, West Grove, PA).
Image acquisition, measurement of luminal circumference, and quantification of proliferation
Images were acquired using a Leica DFC300 FX camera or Leica TCS SP2 confocal system (Leica Microsystems, Bannockburn, IL). For luminal measurement, images of histological sections of wild type and Tmem16a mutant tracheae were visualized in ImageJ (National Institutes of Health).
The apical epithelial surface for each image was traced and converted from pixels to μm by measuring a micrometer in an identical manner. Single litters were analyzed to minimize variation due to staging and processing. Data shown is average ± SEM. An unpaired Student's t-test was performed to confirm significance of the differences in tracheal circumferences at E14.5.
To quantify proliferation, BrdU-positive cells were counted and divided by the total number of cells counted in 1 wild type and 1 mutant at E13.5 for the ventral mesenchyme (200 cells total for each) or 2 animals of each genotype for the epithelium at E14.5. Data shown is average ± SEM.
Results
Tmem16a is expressed in the embryonic tracheal epithelium and trachealis muscle
We performed whole mount and section RNA in situ hybridizations with an antisense riboprobe to detect Tmem16a transcripts during murine tracheal development. At E10.5 we observed Tmem16a expression throughout the epithelia of the foregut and primary lung buds (Fig. 1A ). Tmem16a expression continued in the proximal airway epithelium (trachea and conducting airways of the lung) at E11.5 and E12.5, but was absent from the distal tips of peripheral lung epithelium at these stages (Figs. 1B-D). At E14.5 and E16.5 Tmem16a expression was detected in cells of the tracheal epithelium (Figs. 1E, F). In addition to epithelial expression, intense signal was observed in the mesenchyme dorsal to the trachea (Figs. 1D-F). This dorsal mesenchyme does not form cartilage but instead forms the trachealis muscle which bridges the gaps in the cartilage rings. Tmem16a expression was not detected in the chondrogenic mesenchyme of the ventrolateral trachea at any stage examined (E10.5-E18.5).
TMEM16A is localized to the plasma membrane
Previous reports of immunohistochemistry on gastrointestinal stromal tumor samples showed that human TMEM16A was localized to the plasma membrane, while other members of the TMEM16 family of proteins have been reported on intracellular membranes (Bera et al., 2004; Mizuta et al., 2007; West et al., 2004) . Since Tmem16a is expressed in the distal epithelial cells of the murine lung at E18.5 (Fig. 1G) , we used the cell line KLN 205, which is of murine lung carcinoma origin, to examine the localization of TMEM16A (Kaneko and LePage, 1978) . Overexpression of a vector encoding green fluorescent protein (GFP) in these cells resulted in cytoplasmic localization of GFP (Fig. 1H) . In contrast, a GFP-TMEM16A fusion protein was detected by immunofluorescence on the plasma membrane in KLN 205 cells (Fig. 1I ).
Tmem16a null mice fail to thrive during postnatal life
To investigate the functions of Tmem16a in vertebrate development, we generated a null allele of this gene by homologous recombination in murine embryonic stem (ES) cells ( Fig. 2A) . Germline transmission of this allele, Tmem16a , was confirmed by polymerase chain reaction (PCR). Mice heterozygous for Tmem16a tm1Bdh had no apparent phenotype and were mated to generate Tmem16a tm1Bdh/tm1Bdh pups (hereafter referred to as Tmem16a mutants). rtPCR on Tmem16a mutant embryonic tissue confirmed that, by deleting exon 12 of Tmem16a, we had removed 53 amino acids of the second transmembrane domain and the extracellular loop between the first and second transmembrane domains. This strategy induced a frameshift mutation 3′ of the deletion that placed 7 of 8 Tmem16a transmembrane domains out-of-frame and resulted in a premature termination codon 40 amino acids downstream of the deletion. In addition, the deletion was predicted to aberrantly place the truncated C-terminus extracellularly and prevent translation of the DUF590 domain that is conserved in all TMEM16 proteins. These data indicate that Tmem16a tm1Bdh is a null allele of Tmem16a. Since only a small exon was deleted, it was possible that a truncated form of TMEM16A was made from this allele. Tmem16a heterozygotes were phenotypically wild type, suggesting that if a truncated protein was made it did not function in a dominant negative manner. Greater than 90% of Tmem16a nulls died within the first nine days of postnatal life and no Tmem16a mutants survived longer than 30 days postpartum (Fig. 2B and data not shown) . Tmem16a mutants were born with the expected Mendelian frequency (19/81 or 27%) and newborn mutants had a body weight similar to that of wild type and heterozygous littermates (Fig. 2C) . However, Tmem16a null animals did not gain weight at the same rate as their littermates (Fig. 2C) . Three days after parturition, Tmem16a mutants weighed only~65% as much as their littermates. Tmem16a nulls that survived 21 days postpartum weighed less than half as much as wild type littermates. Milk was observed in the stomachs of Tmem16a null pups suggesting that these pups were able to locate nipples and initiate suckling behavior.
A portion of Tmem16a null pups developed grossly distended bellies within the first postnatal week. Varying amounts of air were encountered in the esophagi, stomachs, and intestines of all Tmem16a null pups upon sacrifice and subsequent dissection (data not shown). This aerophagia was frequently associated with a cyanotic appearance prior to sacrifice and suggested a defect in the development of the upper respiratory and/or digestive tracts in Tmem16a mutants. Neither gross nor histological examination of craniofacial development revealed any obvious patterning defects of the palate, tongue, larynx, or crania of Tmem16a null pups (data not shown).
Tmem16a mutants exhibit defects in tracheal cartilage ring formation
Because Tmem16a was expressed in the developing trachea and the mutant phenotype was consistent with an upper airway anomaly, tracheae were dissected from Tmem16a mutants and littermates and stained with alcian blue to examine cartilage elements. Ventral gaps were observed along the entire rostrocaudal axis of mutant tracheae and the cartilage plates on the bronchi were also abnormally patterned ( Fig. 2D and data not shown) . Transverse sections of Tmem16a mutant tracheae stained with alcian blue and eosin clearly demonstrated multiple disconnected cartilage condensations with intervening epithelial evaginations (compare Figs. 2E and F) . This phenotype was 100% penetrant in Tmem16a mutants; all mutants examined on or after E15.5 exhibited gaps in their cartilage rings (n = 16). In contrast, wild type and heterozygous littermates never exhibited a disruption in the normal cartilage ring pattern (n = 13). Development of the thyroid and cricoid cartilages was not disrupted in Tmem16a mutants (Fig. 2D and data not shown) .
Chondrogenic cells are present in the ventral mesenchyme of Tmem16a mutants
Tracheal cartilage rings develop in the splanchnic mesenchyme surrounding the trachea between E13.5 and E15.5 (Miller et al., 2004) . Expression of Sox9, a high mobility group transcription factor, has been reported in cells fated to form cartilage in the peritracheal mesenchyme beginning at E9.0 (Elluru and Whitsett, 2004) . Since SOX9 is capable of activating the transcription of genes encoding cartilage components including Col2a1 (Lefebvre et al., 1997) and aggrecan (Sekiya et al., 2000) , we utilized SOX9 as an early marker of chondrogenesis. Immunohistochemistry and RNA in situ hybridization revealed that SOX9-positive cells were present in the ventrolateral tracheal mesenchyme of both wild type and Tmem16a mutant embryos at E12.5 and E13.5 (Figs. 3A, B , D, E and data not shown). This suggested that the ventral mesenchymal cells in Tmem16a mutants were specified to undergo chondrogenesis and that upstream paracrine signaling events required for that specification were not disrupted. However, at E14.5 the SOX9-positive cells were partitioned by the epithelium into separate populations in Tmem16a mutants (compare Figs. 3C and F) . These data suggested that prechondrocytes were present in the mutant ventral tracheal mesenchyme but ultimately gave rise to disconnected chondrogenic condensations.
The disruption of the mesenchymal chondrogenic condensations was not due to anomalous cell death or cell proliferation. TdT-mediated dUTP nick end labeling (TUNEL) did not reveal any apoptotic nuclei in mutant tracheae at any stage examined (data not shown). In addition, 5′-bromo-2′-deoxyuridine (BrdU) incorporation did not reveal a change in the proliferative indices of mutant tracheal mesenchyme at E13.5 or the tracheal epithelium at E14.5 ( Supplementary Fig. 1 ).
Abnormal morphology of the trachealis muscle in Tmem16a mutants
Since the developing trachealis muscle expressed high levels of Tmem16a (Figs. 1D-F) and is closely associated with the tracheal epithelium and cartilage rings, we examined its development in Tmem16a mutants. Immunofluorescence with an antibody directed against α-smooth muscle actin revealed a population of smooth muscle cells dorsal to the tracheae in both wild type and Tmem16a mutants at E14.5 (Figs. 3G, H) . In wild type mice (n = 3), spindleshaped cells spanned the entire dorsal aspect of the developing trachea (Fig. 3G) . In Tmem16a mutants (n = 3), the distribution of α-smooth muscle actin-positive cells in the trachealis was severely disrupted. Instead of filaments that spanned the dorsal trachea, we detected this protein with a globular distribution in a cluster of cells dorsal to the trachea in Tmem16a mutants at E14.5 and E18.5 ( Fig. 3H and Supplementary Fig. 2 ). This suggested that TMEM16A was necessary for normal development of the trachealis muscle.
Increased tracheal circumference in Tmem16a null mice
Epithelial evaginations that disrupted the chondrogenic condensations in the ventral tracheal mesenchyme occurred along the entire rostrocaudal axis of Tmem16a mutant tracheae (Figs. 2D, F and 3 ) and we reasoned that this could result from an increase in the circumference of the epithelial tube. In support of this hypothesis, the lumens of mutant tracheae appeared dilated in comparison to those of wild type tracheae (see Figs. 3 and 4) . To quantify this defect, we photographed transverse histological sections of tracheae from Tmem16a mutants and littermates at E13.5 and E14.5 (one section per animal) at the same relative rostrocaudal location. For each image, the luminal circumference of the trachea was measured by outlining the apical surface of the tracheal epithelium using image analysis software (see Materials and methods). At E13.5, the luminal circumference was nearly 40% greater in mutants (n = 2) than heterozygous controls (n = 2) (Fig. 3I ). This defect was even more severe in E14.5 embryos where the epithelial circumference of Tmem16a mutants (n = 3) was 50% larger than wild type and heterozygous littermates (n = 3) (Fig. 3I ).
Ciliated cells are absent from evaginated regions of the tracheal epithelium
The disorganization of Tmem16a mutant tracheal epithelium might have been attributable to abnormal differentiation of epithelial cell types. Ciliated columnar cells and non-ciliated secretory Clara cells are abundant in the mature tracheal epithelium of the mouse (Rawlins and Hogan, 2006) . Although a population of p63-expressing cells is found in the wild type embryonic tracheal epithelium, mature basal cells are not established until late gestation (Daniely et al., 2004) . To assess differentiation, we immunolocalized markers of these epithelial cell types in mutant and wild type newborn tracheae.
Acetylated α-tubulin is localized to the cilia on the apical surfaces of epithelial cells in the trachea (Gomperts et al., 2004) . Immunofluorescence on newborn wild type trachea sections revealed an even distribution of ciliated cells around the tracheal epithelium (Fig. 4A) . In Tmem16a mutant trachea, we observed ciliated cells in the tracheal epithelium with a relatively normal distribution (Fig. 4B) ; the one exception was the evaginated epithelium that persisted until birth. These regions of the mutant tracheae were conspicuously devoid of ciliated cells (arrow in Fig. 4B ). Since ciliated cells were present throughout most of the mutant trachea, we propose that this is the result of the evagination and juxtaposition of two apical surfaces and not a defect in specification of the ciliated lineage. Apical localization of ezrin, a member of the ERM (ezrin, radixin, moesin) protein family, precedes the formation of cilia in tracheal epithelium in air-liquid interface conditions (Huang et al., 2003) . We observed normal apical distribution of ezrin in ciliated cells of Tmem16a mutants (data not shown).
Secretory Clara cells of the murine tracheal epithelium can be identified by the presence of the secretoglobin Scgb1a1 (Perl et al., 2005) . We detected Clara cells throughout the tracheal epithelium of newborn wild type and Tmem16a mutant pups (Figs. 4A, B) . In particular, we detected Scgb1a1-expressing cells in regions of tracheae that had undergone abnormal epithelial evagination.
In the mature pseudostratified epithelium of the mouse trachea, a discontinuous population of basal cells can be identified by expression of the transcription factor p63 (Daniely et al., 2004) . As a multipotent progenitor cell type of the proximal airways, basal cells are capable of restoring tracheal epithelial cell diversity following injury (Hong et al., 2004) . In newborn mice, we observed a normal distribution of p63-positive basal cells in Tmem16a mutant tracheal epithelium (Figs. 4C, D) .
Embryonic tracheal epithelium stratification is lost in Tmem16a mutants
Since we did not observe a change in proliferation, apoptosis or differentiation in Tmem16a mutant tracheal epithelium, we reasoned that the luminal expansion could result from an abnormal arrangement of epithelial cells. The mid-gestational tracheal epithelium of the mouse is reported to comprise 2 to 3 cell layers (Daniely et al., 2004) . To assess tracheal epithelium organization in Tmem16a mutants, we performed immunofluorescence on transverse sections of Tmem16a mutant and wild type tracheae with a Cdh1 antibody to identify basolateral epithelial cell plasma membranes. Sections were counterstained with 4′,6-Diamidino-2′-phenylindole (DAPI) to reveal nuclei. In contrast to the stratified epithelium of the E14.5 wild type tracheae, a majority of the nuclei in the mutant tracheae were located adjacent to the basement membrane (Figs. 4E-H) . As a result of this lateral arrangement of cells, the epithelium was observably thinner. 
Discussion
A novel etiology for tracheomalacia in a murine model
The formation of tracheal cartilage rings normally occurs in the ventrolateral mesenchyme around the tracheal epithelium during mid-embryogenesis. Since Tmem16a was never expressed in the chondrogenic mesenchyme of the trachea, we propose that the cartilage defect observed in Tmem16a mutants was a consequence of the improper organization of Tmem16a mutant tracheal epithelium and/or trachealis muscle where Tmem16a was expressed. We detected a normal population of SOX9-positive prechondrocytes in Tmem16a mutants prior to the appearance of an expanded tracheal lumen, anormal trachealis muscle, and improperly stratified embryonic epithelium. We propose that these primary defects caused evaginations of the tracheal epithelium into the surrounding mesenchyme that disrupted the chondrogenic condensations of the tracheal cartilage rings. The ventral-most SOX9-positive chondrocytes were either physically displaced or respecified as another cell type as a result of the epithelial and smooth muscle defects in Tmem16a mutants. Instead of the C-shaped rings required to prevent the trachea from collapsing during normal respiration, multiple cartilaginous rudiments formed along the entire length of the trachea.
This abnormal arrangement of tracheal cartilage contributed to the aerophagia, cyanosis, and failure to thrive of postnatal Tmem16a mutants. In humans, tracheomalacia is exacerbated by esophageal expansion during feeding and can lead to a failure to thrive similar to what we observed in Tmem16a mutant mice (Ahel et al., 2003) . We are unaware of human patients with the type of primary tracheomalacia observed in Tmem16a mutant mice; however, it is conceivable that trauma, surgery, or unidentified human mutations could result in similar ventral gaps in the tracheal cartilage rings of humans.
Alternative models for the etiology of the tracheomalacia observed in Tmem16a mutant mice exist. It is possible that deletion of Tmem16a from the tracheal epithelium disrupts paracrine signaling from the epithelium to the mesenchyme. Since Sox9 is expressed in Tmem16a mutants in a complete ventrolateral ring of cells surrounding the trachea that do not exhibit a proliferative or apoptotic defect prior to chondrogenesis, we do not believe that this is the case. Instead, our data suggests that the upstream signaling events required for chondrogenesis occurred in the ventral mesenchyme of Tmem16a mutant tracheae.
Defective development of the trachealis muscle in Tmem16a mutants
We identified a defect in the development of the trachealis muscle in Tmem16a mutant mice. In wild type animals this smooth muscle spans the dorsal gaps in the rings of tracheal cartilage and controls the size of the lumen during respiration (Hakansson et al., 1976) . One possibility is that this muscle functions during embryogenesis and is required for normal development of the trachea. It is currently not known whether the defect we observed in the trachealis muscle in Tmem16a mutants contributed to the expansion of the tracheal lumen, abnormal epithelial morphogenesis, and/or abnormal cartilage ring development. We are not aware of other mutants with similar patterning defects in the trachealis muscle as observed in Tmem16a null mice.
Interestingly, the paralog Tmem16a is upregulated during differentiation of muscle in vitro and is associated in vivo with cardiac and skeletal muscle (Mizuta et al., 2007; Tsutsumi et al., 2005) . Tmem16a, Tmem16e, and other paralogs are expressed in other, non-muscular tissues suggesting that their functions are not specific to muscle development (Bera et al., 2004; Mizuta et al., 2007; Rock et al., 2007) . However, the functions of the protein products of these genes might be essential for normal organization or function of muscle and other tissues.
Abnormal morphogenesis of the tracheal epithelium in Tmem16a mutants
We report that mice lacking the transmembrane protein TMEM16A demonstrate defects in organization of the tracheal epithelium during embryogenesis. The cells of the epithelium fail to stratify and most nuclei are located in close proximity to the basement membrane. The defective stratification is not the result of a global loss in apicobasal polarity or improper localization of proteins to the apical surface; in ciliated cells of Tmem16a mutant tracheae, both the cilia and the cytoskeletal linker protein ezrin were properly localized to the apical surface. Furthermore, we demonstrated normal differentiation of Clara cells, ciliated cells, and basal cells in mutant tracheae.
Previous experiments have shown that oriented and asymmetric cell divisions are necessary for stratification of the skin (Lechler and Fuchs, 2005) . One possibility is that similar asymmetric cell divisions are also necessary for tracheal epithelial stratification and require TMEM16A. In support of this hypothesis, Ist2p, the only TMEM16 ortholog identified in the yeast Saccharomyces cerevisiae, has been shown to sort asymmetrically during budding (Takizawa et al., 2000) . This protein, however, is distantly related to TMEM16A and does not necessarily share the same function or distribution.
One vertebrate paralog of TMEM16A, TMEM16E, has been localized primarily to intracellular membranes in cultures of myotubes (Mizuta et al., 2007) . For the paralog TMEM16G (also known as NGEP), one splice isoform has been reported intracellularly while a second isoform has been identified on the plasma membrane (Bera et al., 2004) . We showed that TMEM16A is localized to the plasma membranes of KLN 205 murine lung carcinoma cells where it is possible that this protein mediates cell:cell contacts, intercellular communication, or cellular morphology. The paralog TMEM16G has been shown to promote adhesion between LNCaP cells in culture where it is localized to the plasma membrane in regions of cell:cell contact (Das et al., 2007) . A loss of adhesion between Tmem16a mutant cells could explain the lateral arrangement of cells and lack of stratification of Tmem16a mutant trachea epithelium.
A murine model of tracheomalacia
In humans, the diagnosis of tracheomalacia is complicated because its symptoms overlap with those of other pulmonary disorders and there is no single etiology for this condition. In many cases of tracheomalacia, the condition is self-limiting and conservative treatment is favored (Carden et al., 2005; Greenholz et al., 1986) . In more severe cases, treatment including ventilation and surgery are required. In addition to identifying a novel etiology for tracheomalacia, the Tmem16a mutant mice provide a murine model of severe primary tracheomalacia that could be used to aid in the diagnosis and treatment of this condition.
Currently, very little is known about the embryology and molecular biology of normal tracheal development. We propose that there is a requirement for stratification of the mid-gestational tracheal epithelium in normal development and identify Tmem16a as a novel mediator of development of the tracheal epithelium and trachealis muscle. Furthermore, we show that TMEM16A is required for normal development of the tracheal cartilage rings and that deletion of this protein results in severe primary tracheomalacia in mice.
